Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer

Jingcheng Zhou; Daoquan Dong; Ran Cheng; Yan Wang; Shuqi Jiang; Yuhong Zhu; Longlong Fan; Xiangming Mao; Yaoting Gui; Zesong Li; Xianxin Li; Bentao Shi

doi:10.18632/oncotarget.11889

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer

Jingcheng Zhou, Daoquan Dong, Ran Cheng, Yan Wang, Shuqi Jiang, Yuhong Zhu, Longlong Fan, Xiangming Mao, Yaoting Gui, Zesong Li, Xianxin Li and Bentao Shi _

PDF | HTML | How to cite

Oncotarget. 2016; 7:72767-72776. https://doi.org/10.18632/oncotarget.11889

Metrics: PDF 2075 views | HTML 2140 views | ?

Abstract

Jingcheng Zhou1, Daoquan Dong1, Ran Cheng1, Yan Wang1, Shuqi Jiang2, Yuhong Zhu1, Longlong Fan1, Xiangming Mao1, Yaoting Gui2, Zesong Li4, Xianxin Li1,2,3, Bentao Shi1

1Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China

2Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, Guangdong 518036, China

3Shenzhen Sun Yat-sen Cardiovascular Hospital, Shenzhen, Guangdong 518112, China

4Shenzhen Key Laboratory of Genitourinary Tumor, Shenzhen Second People’s Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong 518035, China

Correspondence to:

Bentao Shi, email: [email protected]

Xianxin Li, email: [email protected]

Keywords: KPNA2, OCT4, bladder cancer, prognostic, nucleo-cytoplasmic transport

Received: July 20, 2016 Accepted: August 31, 2016 Published: September 07, 2016

ABSTRACT

Recent studies show that Karyopherin alpha 2 (KPNA2) is up-regulated in quite a number of cancers and associated with poor prognosis. Here, we found that expression levels of KPNA2 and OCT4 are up-regulated in bladder cancer tissues and significantly associated with primary tumor stage and bladder cancer patients’ poorer prognosis. Our data also showed decreased cell proliferation and migration rates of bladder cancer cell lines when the expression of KPNA2 and OCT4 was silenced. Meanwhile, cell apoptosis rate was increased. Furthermore, Co-IP and immunofluorescence assay showed the KPNA2 interacts with OCT4 and inhibits OCT4 nuclear transportation when KPNA2 was silenced. Thus, we confirmed that up-regulated KPNA2 and OCT4 expression is a common feature of bladder cancer that is correlated with increased aggressive tumor behavior. Also, we propose that KPNA2 regulates the process of OCT4 nuclear transportation in bladder cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11889

Publication Alerts

Research Papers:

Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer

Abstract